Posts for Oculis Holding AG ($OCS)

Explore Oculis Holding AG's significant $100M capital raise through a share offering. Key details on underwriters, pricing, and regulatory compliance included.

Oculis Holding AG reports strong cash position and promising Phase 2 ACUITY trial results for OCS-05, indicating potential market opportunities in treating acute optic neuritis.